Sign in
CYTHW Stock Price, Chart, Stats & News
Cyclo Therapeutics, Inc.
Save
Cyclo Therapeutics, Inc. (CYTHW) does not currently pay a dividend.
899,367
Market cap
–
Current P/E
–
Forward P/E
CYTHW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 90.85% |
Operating margin | -1862.69% |
Pretax margin | -1863.36% |
Net margin | -1863.36% |
Effective tax rate | – |
ROA | -151.40% |
ROE | -730.48% |
D/E | 0.22x |
Interest coverage ratio | – |
CYTHW valuation
P/E | – |
P/S | 21.92x |
P/B | 2.47x |
P/CF | -0.73x |
P/FCF | -1.46x |
P/OCF | -0.73x |
PEG | 0.26x |
EV multiple | -1.59x |
About
Cyclo Therapeutics, Inc. is dedicated to developing biopharmaceutical treatments derived from cyclodextrin to combat various illnesses. A central component of their research and development pipeline is Trappsol Cyclo, a therapeutic specifically targeting Niemann-Pick Type C disease and Alzheimer's disease. Charles E.
Similar securities
Based on sector and market capitalization
Report issue